Acute coronary findings at autopsy in heart failure patients with sudden death - Results from the Assessment of Treatment with Lisinopril and Survival (ATLAS) Trial

被引:246
作者
Uretsky, BF
Thygesen, K
Armstrong, PW
Cleland, JG
Horowitz, JD
Massie, BM
Packer, M
Poole-Wilson, PA
Ryden, L
机构
[1] Aarhus Univ Hosp, Aarhus, Denmark
[2] Univ Texas, Med Branch, Galveston, TX 77550 USA
[3] Univ Hull, Hull HU6 7RX, N Humberside, England
[4] Univ Alberta, Edmonton, AB T6G 2M7, Canada
[5] Univ Adelaide, Adelaide, SA 5005, Australia
[6] Univ Calif San Francisco, San Francisco, CA 94143 USA
[7] Columbia Univ, New York, NY 10027 USA
[8] Univ London Imperial Coll Sci Technol & Med, Sch Med, London SW7 2AZ, England
[9] Karolinska Inst, Stockholm, Sweden
关键词
death; sudden; heart failure; ischemia;
D O I
10.1161/01.CIR.102.6.611
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Sudden unexpected death frequently occurs in chronic heart failure. The importance of acute coronary events in triggering sudden death (SD) is unclear. Methods and Results-We evaluated at autopsy the prevalence of acute coronary findings (coronary thrombus, ruptured plaque, or myocardial infarction [MI]) and their relation to SD. Autopsy results in 171 patients in the randomized ATLAS trial were reviewed, The prevalence of acute coronary findings was 33%: in 54% of patients with significant coronary artery disease (CAD) who died suddenly, 32% who died of myocardial failure, but in non-CAD patients, they were present in only 5% and 10% respectively. The percentage of patients classified as dying of MI was 28% in the autopsy group versus 4% in the nonautopsied group (P<0.0001). Of the autopsied group with acute MI, 97% (31 of 32 patients) with SD and 40% (6 of 15 patients) with myocardial failure did not have the MI diagnosed during life, When undiagnosed MI was classified as "sudden unexpected" or "myocardial failure:' from clinical information only, the distribution of death causes was similar in the autopsy and nonautopsied groups. Conclusions-Acute coronary findings are frequent and usually not clinically diagnosed in heart failure patients with CAD, particularly in those dying suddenly, suggesting the importance of acute coronary events as a trigger for SD in this setting.
引用
收藏
页码:611 / 616
页数:6
相关论文
共 22 条
[1]   Antiplatelet agents and survival: A cohort analysis from the studies of left ventricular dysfunction (SOLVD) trial [J].
Al-Khadra, AS ;
Salem, DN ;
Rand, WM ;
Udelson, JE ;
Smith, JJ ;
Konstam, MA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) :419-425
[2]  
BABA N, 1975, CIRCULATION S3, V53, P53
[3]  
BALL SG, 1993, LANCET, V342, P821
[4]  
BASHE WJ, 1975, CIRCULATION S3, V53, P63
[5]   Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT [J].
Cairns, JA ;
Connolly, SJ ;
Roberts, R ;
Gent, M .
LANCET, 1997, 349 (9053) :675-682
[6]   EFFECT OF VASODILATOR THERAPY ON MORTALITY IN CHRONIC CONGESTIVE-HEART-FAILURE - RESULTS OF A VETERANS-ADMINISTRATION COOPERATIVE STUDY [J].
COHN, JN ;
ARCHIBALD, DG ;
ZIESCHE, S ;
FRANCIOSA, JA ;
HARSTON, WE ;
TRISTANI, FE ;
DUNKMAN, WB ;
JACOBS, W ;
FRANCIS, GS ;
FLOHR, KH ;
GOLDMAN, S ;
COBB, FR ;
SHAH, PM ;
SAUNDERS, R ;
FLETCHER, RD ;
LOEB, HS ;
HUGHES, VC ;
BAKER, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (24) :1547-1552
[7]   A COMPARISON OF ENALAPRIL WITH HYDRALAZINE ISOSORBIDE DINITRATE IN THE TREATMENT OF CHRONIC CONGESTIVE-HEART-FAILURE [J].
COHN, JN ;
JOHNSON, G ;
ZIESCHE, S ;
COBB, F ;
FRANCIS, G ;
TRISTANI, F ;
SMITH, R ;
DUNKMAN, WB ;
LOEB, H ;
WONG, ML ;
BHAT, G ;
GOLDMAN, S ;
FLETCHER, RD ;
DOHERTY, J ;
HUGHES, CV ;
CARSON, P ;
CINTRON, G ;
SHABETAI, R ;
HAAKENSON, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (05) :303-310
[8]  
DAVIES MJ, 1992, CIRCULATION, V85, P19
[9]   RANDOMIZED TRIAL OF LOW-DOSE AMIODARONE IN SEVERE CONGESTIVE-HEART-FAILURE [J].
DOVAL, HC ;
NUL, DR ;
GRANCELLI, HO ;
PERRONE, SV ;
BORTMAN, GR ;
CURIEL, R .
LANCET, 1994, 344 (8921) :493-498
[10]   MORTALITY AND MORBIDITY IN PATIENTS RECEIVING ENCAINIDE, FLECAINIDE, OR PLACEBO - THE CARDIAC-ARRHYTHMIA SUPPRESSION TRIAL [J].
ECHT, DS ;
LIEBSON, PR ;
MITCHELL, LB ;
PETERS, RW ;
OBIASMANNO, D ;
BARKER, AH ;
ARENSBERG, D ;
BAKER, A ;
FRIEDMAN, L ;
GREENE, HL ;
HUTHER, ML ;
RICHARDSON, DW .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (12) :781-788